Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Cash from Operations (2023 - 2026)

Cannabis Bioscience International Holdings' Cash from Operations history spans 4 years, with the latest figure at 14597.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 82.37% to 14597.0 in Q1 2026 year-over-year; TTM through Feb 2026 was 268114.0, a 25.47% increase, with the full-year FY2025 number at 329627.0, up 31.24% from a year prior.
  • Cash from Operations hit 14597.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from 5493.0 in the prior quarter.
  • Over the last five years, Cash from Operations for CBIH hit a ceiling of 5493.0 in Q4 2025 and a floor of 221247.0 in Q4 2023.
  • Historically, Cash from Operations has averaged 101680.08 across 4 years, with a median of 82812.0 in 2025.
  • Biggest five-year swings in Cash from Operations: soared 95.49% in 2024 and later plummeted 812.43% in 2025.
  • Tracing CBIH's Cash from Operations over 4 years: stood at 221247.0 in 2023, then skyrocketed by 67.42% to 72090.0 in 2024, then soared by 92.38% to 5493.0 in 2025, then plummeted by 165.74% to 14597.0 in 2026.
  • Business Quant data shows Cash from Operations for CBIH at 14597.0 in Q1 2026, 5493.0 in Q4 2025, and 103712.0 in Q3 2025.